Chamaine Brooks
Family Medicine · Laurinburg, NCNPI 1619139029
Payments from drug & device makers
Across 154 payments — averaging $17.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$478
- Novo Nordisk$471
- Ardelyx, Inc.$254
- AstraZeneca$202
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$167
- Lilly USA, LLC$107
- plus $955 from 21 others
What the payments were for
- Food & beverage$2,60299%
- Education$321%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 25 | $478 |
| Novo Nordisk | 29 | $471 |
| Ardelyx, Inc. | 10 | $254 |
| AstraZeneca | 12 | $202 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $167 |
| Lilly USA, LLC | 8 | $107 |
| Sanofi-aventis U.S. LLC | 6 | $103 |
| Boehringer Ingelheim | 6 | $94 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $80 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $75 |
| Otsuka America Pharmaceutical, Inc. | 4 | $71 |
| Amgen | 5 | $69 |
| Amarin Pharma, Inc. | 3 | $54 |
| Pfizer | 4 | $54 |
| Corcept Therapeutics | 3 | $47 |
| Merck | 4 | $44 |
| GSK | 3 | $43 |
| Exact Sciences | 2 | $37 |
| Mylan Specialty L.p. | 2 | $30 |
| Dynavax Technologies Corporation | 2 | $29 |
| Boston Scientific | 1 | $28 |
| Bayer | 1 | $20 |
| Edwards Lifesciences | 1 | $19 |
| Dexcom, Inc. | 1 | $16 |
| Shield Therapeutics Inc | 1 | $15 |
| Eisai Inc. | 1 | $14 |
| Novartis | 1 | $14 |
How this compares
$2,634 in reported general payments places this provider in the 80th percentile of 3,444 family medicine providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 356 | $358,518 |
| MounjaroTirzepatide | 187 | $204,579 |
| JardianceEmpagliflozin | 142 | $162,750 |
| LinzessLinaclotide | 129 | $112,378 |
| EliquisApixaban | 109 | $98,924 |
| TrulicityDulaglutide | 83 | $83,779 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 79 | $59,673 |
| RexultiBrexpiprazole | 30 | $51,260 |
| JanuviaSitagliptin Phosphate | 34 | $33,586 |
| FarxigaDapagliflozin Propanediol | 41 | $32,760 |
| TradjentaLinagliptin | 23 | $29,370 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 27 | $27,747 |
| RybelsusSemaglutide | 13 | $26,557 |
| Breo ElliptaFluticasone/Vilanterol | 42 | $24,114 |
| TrintellixVortioxetine Hydrobromide | 21 | $23,076 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $471 | $385,076369 claims |
| Lilly USA, LLCMounjaro, Trulicity | $107 | $288,358270 claims |
| Boehringer IngelheimJardiance, Tradjenta, Synjardy Xr, Stiolto Respimat, Spiriva Respimat | $94 | $236,831228 claims |
| AbbVieLinzess | $478 | $112,378129 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Shingrix, Arnuity Ellipta | $43 | $109,558195 claims |
| PfizerEliquis | $54 | $98,924109 claims |
| MerckJanuvia, Janumet Xr, Janumet | $44 | $73,41173 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $71 | $51,26030 claims |
| AstraZenecaFarxiga | $202 | $32,76041 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $75 | $23,07621 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $167 | $11,68413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,444 family medicine providers in North Carolina.
Other family medicine in Laurinburg
- Barton WilliamsWilmington$17.3M
- Alexander MurrayGreensboro$13M
- Arin PiramzadianJacksonville$13M
- Jonathan WilsonHickory$12.7M
- George RaadCharlotte$7.7M
- Cecil FarringtonSalisbury$6.4M
- Christian MartinShelby$5.4M
- John EarlHickory$4.7M
- Patrick MorganteHavelock$4.6M
- Stephen JonesShelby$4.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.